Assessment of sexual dysfunction in patients with benign prostatic hyperplasia

被引:38
|
作者
Rosen, RC [1 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA
关键词
ejaculation; erection; self-administered questionnaire; sexual dysfunction; erectile dysfunction; sexual satisfaction; LUTS;
D O I
10.1111/j.1464-410X.2006.06103.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Sexual dysfunction is a highly prevalent condition in ageing men that considerably affects their quality of life, although it is a frequently neglected aspect of healthcare. The main predictors of sexual dysfunction are age and cardiovascular comorbidities such as hypertension, heart disease, hypercholesterolaemia and diabetes. Recently, the severity of lower urinary tract symptoms (LUTS) has also been identified as a crucial risk factor for sexual dysfunction, independent of age and comorbidities. Despite the increased prevalence of sexual dysfunction with age, health-related problems and psychological factors, there is evidence that many older men remain sexually active. Currently available self-administered questionnaires assessing male sexual dysfunction focus almost exclusively on erectile function. There is evidence from recent large-scale epidemiological studies that ejaculatory dysfunction (EjD) is almost as prevalent as erectile dysfunction (ED), affecting nearly half of men aged >= 50 years. Other domains such as orgasm, desire, and satisfaction with sex life are important and should be considered. There is thus a need to develop and validate more comprehensive and multidimensional instruments for assessing sexual dysfunction in ageing men. A new instrument, the Male Sexual Health Questionnaire (MSHQ), was developed and validated to assess these specific aspects of male sexual dysfunction . It consists of a 25-item self-administered questionnaire including three core domains (erection, ejaculation, satisfaction with sex life) and additional items related to sexual activity, desire and bother related to sexual dysfunction. The MSHQ scale has excellent psychometric properties and is well suited for use in clinical and research settings. A short form of the MSHQ scale is currently under development.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 50 条
  • [21] Update on the Sexual Impact of Treatment for Benign Prostatic Hyperplasia
    John Roger Bell
    Eric Laborde
    Current Urology Reports, 2012, 13 : 433 - 440
  • [22] Sexual complications of minimally invasive surgical therapy for benign prostatic hyperplasia
    Lebed B.D.
    Jaffe W.I.
    Te A.E.
    Current Sexual Health Reports, 2006, 3 (2) : 76 - 82
  • [23] The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction
    Bearelly, Priyanka
    Avellino, Gabriella Juliet
    FERTILITY AND STERILITY, 2021, 116 (03) : 611 - 617
  • [24] Prevalence of ejaculatory dysfunction secondary to alpha-blocker therapy in patients with benign prostatic hyperplasia
    Martin-Morales, A.
    Meyer, G.
    Ramirez, E.
    ACTAS UROLOGICAS ESPANOLAS, 2008, 32 (07): : 705 - 712
  • [25] Update on the Sexual Impact of Treatment for Benign Prostatic Hyperplasia
    Bell, John Roger
    Laborde, Eric
    CURRENT UROLOGY REPORTS, 2012, 13 (06) : 433 - 440
  • [26] Identifying patients with benign prostatic hyperplasia through a diagnosis of, or treatment for, erectile dysfunction
    McVary, Kevin
    Foley, Kathleen A.
    Long, Stacey R.
    Sander, Stephen
    Curtice, Tammy G.
    Shah, Hemal
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (03) : 775 - 784
  • [27] Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
    Shin, Yu Seob
    Karna, Keshab Kumar
    Choi, Bo Ram
    Park, Jong Kwan
    WORLD JOURNAL OF MENS HEALTH, 2019, 37 (02) : 157 - 165
  • [28] Depressive symptoms in patients diagnosed with benign prostatic hyperplasia
    Pietrzyk, Barbara
    Olszanecka-Glinianowicz, Magdalena
    Owczarek, Aleksander
    Gabryelewicz, Tomasz
    Almgren-Rachtan, Agnieszka
    Prajsner, Andrzej
    Chudek, Jerzy
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (03) : 431 - 440
  • [29] Improvement of the symptoms of lower urinary tract and sexual dysfunction with tadalafil and solifenacin after the treatment of benign prostatic hyperplasia with dutasteride
    Kosilov, Kirill, V
    Kuzina, Irina G.
    Kuznetsov, Vladimir
    Kosilova, Ekaterina K.
    PROSTATE INTERNATIONAL, 2020, 8 (02) : 78 - 84
  • [30] Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction
    Calogero, Aldo E.
    Burgio, Giovanni
    Condorelli, Rosita A.
    Cannarella, Rossella
    La Vignera, Sandro
    AGING MALE, 2019, 22 (01) : 12 - 19